TCL Archive FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin April 5, 1985
TCL Archive NCAB Subcommittee Calls For Review Of Organ Site Program, Consideration Of One For Lung Cancer May 1, 1981
TCL Archive DCT Board Approves Three New BRMP RFAs For Immunologic Research, $1.5 Million A Year February 27, 1987
TCL Archive FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug July 26, 2013